In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deanna Kamienski

Senior Deals Analyst, Strategic Transactions

Deanna has been with Strategic Transactions since 2000. In her role she researches, analyzes, and writes summaries of alliances, M&A, and fundraising activities among global biopharma and medtech companies. Deanna oversees the two Dealmaking columns and authors a Quarterly Statistics article, in addition to contributing content to In Vivo. Prior to joining Strategic Transactions, Deanna worked at Yale University, first in the Office of Medical Development as a gift support services coordinator assisting in fundraising activities and producing fund reports and donor gift acknowledgements. Later she worked at Yale's Department of Epidemiology and Public Health as a research assistant performing various tasks including editing the School of Public Health's website, identifying new funding prospects, providing grant support for the Dean, and preparing development materials and reports. Deanna holds a Bachelor of Science degree from the University of Vermont. In her spare time she enjoys boating and fishing with her family and friends.
Advertisement
Set Alert for Articles By Deanna Kamienski

Latest From Deanna Kamienski

Venture Funding Deals: Vedanta Raises More Cash To Advance Microbiome Candidates

Cancer drug-developer Black Diamond emerges from stealth mode with Series A and closes Series B in the same month, while aging-focused Juvenescence closes its initial tranche and looks complete Series B by the end of the quarter. 

Deals Financing

Deals Shaping The Medical Industry, February 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2019.

BioPharmaceutical Medical Device

Start-Up Quarterly Statistics: Relay, Cerevel Financings Lead Q4 VC Deals

A review of biopharma start-up dealmaking and financing activity from October through December 2018, based on data from Strategic Transactions.

Deals Financing

Deals Shaping The Medical Industry, January 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2018.

Deals Market Intelligence

Venture Funding Deals: Relay Closes Out 2018 With $400m Series C

2018 was a banner year for venture funding, and Relay's December Series C was only the third largest VC round of the year. Other year-end financings include Millendo, Erasca, Aristea and more... 

Deals Financing

Deals Shaping The Medical Industry, December 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2018.

Deals BioPharmaceutical
See All
Advertisement
UsernamePublicRestriction

Register